Physician profile
Darrell Hutchison
NPI 1962441436
$661.01
in general payments reported to CMS, 2019-2025
14 companies · $70.66 in 2025
The $70.66 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $55.62 · 2020: $57.96 · 2021: $62.73 · 2022: $233 · 2023: $125 · 2024: $56.27 · 2025: $70.66.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $252.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $251.53 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $253.36 | 2021-2023 | Trelegy Ellipta, Shingrix, Arexvy |
| Pfizer INC. | $79.41 | 2022-2023 | |
| Novo Nordisk INC | $69.38 | 2019-2022 | |
| Sanofi Pasteur INC. | $45.89 | 2022-2024 | |
| Astrazeneca Pharmaceuticals LP | $43.00 | 2020-2025 | Farxiga |
| Abbott Laboratories | $37.41 | 2021-2025 | Freestyle Libre 3 |
| Seqirus USA INC | $30.21 | 2025 | Flucelvax, Fluad |
| Mylan Specialty L.P. | $18.18 | 2020 | |
| Genzyme Corporation | $16.11 | 2024 | |
| Lilly USA, LLC | $15.63 | 2023 | Jardiance |
| Sunovion Pharmaceuticals INC. | $15.52 | 2020 | |
| Amgen INC. | $13.44 | 2024 | |
| Merck Sharp & Dohme LLC | $11.80 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $11.67 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Darrell Hutchison listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.